Bradycardia Recognition and Detection in Young Infants Part-I

NCT ID: NCT05774470

Last Updated: 2024-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-22

Study Completion Date

2023-07-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective cohort study will determine the diagnostic accuracy of the Owlet OSS 3.0 monitor for the detection of episodes of bradycardia and/or hypoxemia among infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will attach an Owlet monitor to infants for a 48-hour period. We will prospectively collect data from this device to determine the accuracy of bradycardia and hypoxemia detection compared with hospital monitors. In addition, we will collect simultaneous high-resolution real time cardiorespiratory data from Philips MP70 patient monitors at the University of Alabama at Birmingham.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Bradycardia Hypoxemia of Newborn

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Owlet OSS 3.0

The Owlet OSS 3.0 is a non-invasive monitoring device. The Sock secures the Sensor to the baby's foot. The Sensor measures the baby's SpO2, heart rate, and movement, and transmits the baby's readings to the Base Station. The Base Station records and monitors the baby's readings and can indicate prompts as needed based on the data sent from the Sensor.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Off ventilatory support/NCPAP/HFNC and phototherapy for \> 48 hours
* Less than one-year corrected age
* Current weight \>1500 grams
* Parents/legal guardians have provided consent for enrollment

Exclusion Criteria

* a major malformation
* a neuromuscular condition that affects respiration or causes apnea
* active skin breakdown or skin infection
* terminal illness or decision to withhold or limit support
* We will exclude data from infants who develop shock/sepsis or require ventilatory support or phototherapy during the study period.
Minimum Eligible Age

1 Day

Maximum Eligible Age

365 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Owlet Baby Care, Inc.

INDUSTRY

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Colm Travers

Assistant Professor of Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Colm P Travers, MD

Role: PRINCIPAL_INVESTIGATOR

University of Alabama at Birmingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UAB Hospital

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Travers CP, Nakhmani A, Armstead KM, Benz RL, Foshee KM, Carlo WA. Diagnostic accuracy of an over-the-counter infant pulse oximeter for cardiorespiratory events. Arch Dis Child Fetal Neonatal Ed. 2025 May 12:fetalneonatal-2025-328540. doi: 10.1136/archdischild-2025-328540. Online ahead of print.

Reference Type DERIVED
PMID: 40355254 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

300010237

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Non-invasive Ventilation in Preterm Infants
NCT05987800 ACTIVE_NOT_RECRUITING NA
Long QT Syndrome Screening in Newborns
NCT02412709 UNKNOWN PHASE2